A new panel of federal immunization advisers, appointed by HHS Secretary Robert F. Kennedy Jr., showcases their extensive expertise in vaccines and science, sparking discussions on public health.
In a landmark decision, the Trump administration vows to overhaul the regulations on prescription drug advertising. This move aims to ensure consumers receive accurate information about the risks and benefits of medications, combatting misleading ads that favor expensive drugs over affordable generics.
Frustrated seniors across the nation report being denied COVID-19 vaccinations due to new policies. As cases rise, many are left scrambling for access amid bureaucratic hurdles and healthcare regulations.
Kenvue Inc. faces a significant drop in shares after reports suggest that Tylenol may be linked to autism. The speculation arises as the government prepares to release findings on autism this month.
Jim O’Neill steps in as acting CDC director, replacing Susan Monarez amid controversy over vaccine policies. With ties to RFK Jr. and a libertarian stance, will he advocate for public health or follow orders?
CVS has announced major changes to COVID vaccine availability, offering shots in 34 states and requiring prescriptions in 13 others, leaving many Americans confused amid a new variant surge.
In a surprising turn of events, the White House has named a new acting head for the CDC after significant departures linked to vaccine policy disagreements. Who is stepping in?
In a dramatic shakeup, Jim O'Neill has been appointed as the acting director of the CDC following the ousting of Susan Monarez. This transition comes amidst widespread resignations and controversy surrounding the agency's leadership and vaccine policies.
In a major shift, the FDA has approved updated Covid boosters while restricting access for children under 5, raising concerns among parents and health experts. Learn about the new guidelines and their implications.
In a controversial 5-4 ruling, the Supreme Court temporarily halted $783 million in NIH research grants, igniting debates over the Trump administration's funding cuts and the implications for scientific research.
